Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report)’s share price was up 0.2% during trading on Thursday . The stock traded as high as €21.77 ($22.68) and last traded at €21.54 ($22.44). Approximately 3,248,785 shares were traded during trading, The stock had previously closed at €21.50 ($22.39).
Bayer Aktiengesellschaft Stock Performance
The company has a quick ratio of 0.72, a current ratio of 1.27 and a debt-to-equity ratio of 129.94. The company’s 50-day moving average is €19.89 and its two-hundred day moving average is €24.25. The company has a market cap of $21.26 billion, a P/E ratio of -16.78, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Recommended Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Find and Profitably Trade Stocks at 52-Week Lows
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What Investors Need to Know to Beat the Market
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- What Are Dividend Achievers? An Introduction
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
